Sfoglia per AUTORE
CHEN H
Collezione AOU San Luigi di Orbassano
Items : 3
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy. in European urology oncology / Eur Urol Oncol. 2024 Feb;7(1):112-121. doi: 10.1016/j.euo.2023.06.006. Epub 2023 Jul 18.
2024
AOU San Luigi di Orbassano
AOU Novara
AOU San Luigi di Orbassano
AOU Novara
Wang L; Qu L; Chen C; Li M; Feng X; Ge J; Zheng J; Wang S; Zhou X; Shi B; Xue W; Wang Z; Qin W; Chen M; Guo H; Zu X; Jiang J; Xia D; Liu Z; Wang G; Liang C; Xu N; Wang J; Rao Q; Miao H; Cheng J; Wang F; Gao J; Wang H; et alii...
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. in The oncologist / Oncologist. 2022 Oct 1;27(10):e783-e795. doi: 10.1093/oncolo/oyac172.
2022
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Mehra N; Fizazi K; de Bono JS; Barthélémy P; Dorff T; Stirling A; Machiels JP; Bimbatti D; Kilari D; Dumez H; Buttigliero C; van Oort IM; Castro E; Chen HC; Di Santo N; DeAnnuntis L; Healy CG; Scagliotti GV;
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Sep;22(9):1250-1264. doi: 10.1016/S1470-2045(21)00376-4. Epub 2021 Aug 10.
2021
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
de Bono JS; Mehra N; Scagliotti GV; Castro E; Dorff T; Stirling A; Stenzl A; Fleming MT; Higano CS; Saad F; Buttigliero C; van Oort IM; Laird AD; Mata M; Chen HC; Healy CG; Czibere A; Fizazi K;